| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |